# Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

> **NCT01736696** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 59 (actual)

## Conditions studied

- Psoriasis
- Immunomodulation

## Interventions

- **DRUG:** tofacitinib
- **DRUG:** tofacitinib
- **DRUG:** tofacitinib
- **DRUG:** tofacitinib
- **DRUG:** tofacitinib
- **DRUG:** tofacitinib

## Key facts

- **NCT ID:** NCT01736696
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736696, "Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01736696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*